Restless Legs Syndrome affects 5-10% of adults. New guidelines show dopamine agonists are no longer first-line due to augmentation risks. Alpha-2-delta ligands like pregabalin are now preferred. Lifestyle changes and iron supplements also help manage symptoms.
Read More